Clinical performance of a new two-rod levonorgestrel contraceptive implant: A three-year randomized study with Norplant® implants as controls

Contraception

Volumn 55, Issue 2, 1997, Pages 73-80

  Sivin, Irving ^a   Viegas, Osborn ^b   Campodonico, Italo ^c   Diaz, Soledad ^d   Pavez, Margarita ^d   Wan, Livia ^e   Koetsawang, Suporn ^f   Kiriwat, Orawan ^f   Piya Anant, Manee ^f   Holma, Pentti ^g   El Din Abdalla, Kamal ^g   Stern, Janet ^a  

^a POPULATION COUNCIL   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^d Instituto Chileno de Medicina Reproductive (ICMER)   (Chile)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAHIDOL UNIVERSITY   (Thailand)

^g MINIA UNIVERSITY   (Egypt)

Author keywords

concomitant adverse effects; efficacy; implant contraception; levonorgestrel rod; removals

Indexed keywords

LEVONORGESTREL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPLANT; FEMALE; HEADACHE; HUMAN; MENSTRUATION DISORDER; MULTICENTER STUDY; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

CLINICAL RESEARCH; CLINICAL TRIALS; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTION TERMINATION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE IMPLANTS; CONTRACEPTIVE METHODS; FAMILY PLANNING; LEVONORGESTREL; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CAPSULES; CHILE; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; EGYPT; FEMALE; FINLAND; HUMANS; INCIDENCE; LEVONORGESTREL; MENSTRUATION DISTURBANCES; PREGNANCY; PREGNANCY RATE; SINGAPORE; THAILAND; UNITED STATES;

EID: 8044258976     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(96)00275-2     Document Type: Article

References (15)

1. Robertson DN, Sivin I, Nash HA, Braun H, Dinh J. Release of levonorgestrel from Silastic® capsules, homogeneous rods and covered rods in humans. Contraception 1983;27:483-95.
2. Roy S, Mishell DR Jr, Robertson DN, Krauss RM, Lacarra M, Duda MJ. Long-term reversible contraception with levonorgestrel-releasing Silastic rods. Am J Obstet Gynecol 1984;148:1006-13.
3. Sivin I. International experience with Norplant and Norplant®-2 contraceptives. Stud Fam Plann 1988;19: 81-94.
4. Koetsawang S, Kiriwat O, Piya-Anant M, et al. Experience with Norplant®-2 in Thai women. In Ratnam SS, Teoh E-S, Lim S-M, eds. Advances in fertility and sterility, series v6: contraception. Carnforth, UK: The Parthenon Publishing Group, 1987:133-42.
5. Gu S-J, Du M-K, Yuan D-Y, et al. A two-year study of acceptability, side effects, and effectiveness of Norplant® and Norplant®-2 implants in the People's Republic of China. Contraception 1988;38:641-57.
6. Singh K, Viegas OAC, Ratnam SS. Acceptability of Norplant®-2 as a method of family planning. Contraception 1992;45:453-61.
7. Indian Council for Medical Research (ICMR) Task Force on Hormonal Contraception. Phase III clinical trial with Norplant®-II(two covered rods): report on five years of use. Contraception 1993;48:120-32.
8. Gu S-J, Du M-K, Zhang L-d, et al. A five-year evaluation of Norplant®-II implants in China. Contraception 1994; 50:27-34.
9. Singh K, Viegas OAC, Fong YF, Ratnam SS. Acceptability of Norplant® implants for fertility regulation in Singapore. Contraception 1992;45:39-47.
10. Sivin I. Contraception with Norplant® implants. Human Reprod 1994;9:1818-26.
11. WHO Adverse reaction dictionary. Uppsala: Sweden, 31 Dec 1993.
12. Fowler, P. Subdermal implants - still a viable long-term contraceptive option? Brit J Family Plann 1996;22:31-3.
13. Sivin I, Stern J, Diaz S, et al. Rates and outcomes of planned pregnancy after use of Norplant capsule, Norplant-II rods or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol 1992;166:1208-13.
14. Indian Council of Medical Research (ICMR) Task Force on Hormonal Contraception. Return of fertility following discontinuation of Norplant-II subdermal implants. Contraception 1995;51:237-42.
15. Trussell J, Leveque JA, Koenig JD, et al. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85:494-503.